Edition:
United States

Health News

Correvio suffers fresh blow as heart drug fails to win FDA panel backing

Independent experts to the U.S. Food and Drug Administration on Tuesday voted against Correvio Pharma Corp's drug to correct irregular rhythm in the upper chambers of the heart in adult patients, the latest setback to the company's efforts to market a potential blockbuster in the country.

Health Reform Watch